OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment of Idiopathic Pulmonary Fibrosis by Inhaled Silybin Dry Powder Prepared via the Nanosuspension Spray Drying Technology
Xinai Ma, Kexin Xia, Jianjun Xie, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 6, pp. 878-891
Closed Access | Times Cited: 5
Xinai Ma, Kexin Xia, Jianjun Xie, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 6, pp. 878-891
Closed Access | Times Cited: 5
Showing 5 citing articles:
Nanosuspension-Based Drug Delivery Systems for Topical Applications
Mohamed Aldeeb, Gofarana Wilar, Cecep Suhandi, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 825-844
Open Access | Times Cited: 25
Mohamed Aldeeb, Gofarana Wilar, Cecep Suhandi, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 825-844
Open Access | Times Cited: 25
Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
Shery Jacob, Fathima Sheik Kather, Sai H. S. Boddu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 136-136
Open Access | Times Cited: 3
Shery Jacob, Fathima Sheik Kather, Sai H. S. Boddu, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 136-136
Open Access | Times Cited: 3
Network Pharmacology-driven therapeutic interventions for Interstitial Lung Diseases using Traditional medicines: A Narrative Review
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Megh Pravin Vithalkar, K. Sandra, Bharath Harohalli Byregowda, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113979-113979
Open Access | Times Cited: 1
Liposome-Based Silibinin for Mitigating Nonalcoholic Fatty Liver Disease: Dual Effects via Parenteral and Intestinal Routes
Baofei Yan, Xian Zheng, Yun Wang, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 12, pp. 1909-1923
Open Access | Times Cited: 9
Baofei Yan, Xian Zheng, Yun Wang, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 12, pp. 1909-1923
Open Access | Times Cited: 9
Silibinin Targeting Heat Shock Protein 90 Represents a Novel Approach to Alleviate Nonalcoholic Fatty Liver Disease by Simultaneously Lowering Hepatic Lipotoxicity and Enhancing Gut Barrier Function
Baofei Yan, Xian Zheng, Xi Chen, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2110-2124
Closed Access | Times Cited: 1
Baofei Yan, Xian Zheng, Xi Chen, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2110-2124
Closed Access | Times Cited: 1
